NVDA 211.94 ▲2.56%GOOGL 377.65 ▲1.11%MSFT 492.81 ▲1.06%AMD 518.58 ▲7.00%INTC 100.86 ▲10.84%TSMC 417.17 ▲2.72%AMZN 277.42 ▼2.32%META 587.94 ▼0.39%AAPL 309.38 ▲1.96%PLTR 162.66 ▲29.45%
Markets at last close

Oracle · Business

Oracle gains CMS status as AI spending accelerates

·1 min read

Oracle shares gained 1.44% to $177.58 on April 20, 2026, after the company secured designation as a CMS Aligned Network, giving it access to the Centers for Medicare & Medicaid Services ecosystem. The status supports the agency’s “Kill the Clipboard” initiative, with Oracle’s integrated CLEAR1 platform, certified to NIST IAL2/AAL2, enabling patients to verify identity by QR code and send intake data into electronic health records. AtlantiCare has implemented the tools across its outpatient operations.

The healthcare milestone came alongside stronger results: third fiscal quarter revenue was $17.19 billion, up 21.7% year over year, and earnings per share reached $1.79, above the consensus estimate of $1.71. Trading volume reached 44.67 million shares, about 56% above the 20-day average.

Oracle is also committing heavily to AI infrastructure, with total revenue of $17.2 billion last quarter and cloud growth of 44%. Infrastructure cloud revenue rose 84%, while remaining performance obligation stood at $553 billion, including contracts with Meta, xAI and OpenAI; OpenAI alone was estimated at $30 billion annually. Planned capital expenditures of roughly $50 billion for fiscal 2026 are pushing free cash flow negative and are expected to lift debt above $100 billion.

Execution risk remains central. OpenAI delayed expansion of its Texas-based “Stargate” project while waiting for newer Nvidia chips, and analyst price targets range from $155 to $400 per share. Oracle is also preparing direct cloud infrastructure interconnects with Amazon Web Services by the end of 2026, tying its upside to sustained AI demand and timely delivery.

Originally reported by stockstoday.comRead the source →
Related coverage
All Oracle news →